Federal Pharmacy Senior Leaders Vision: Next Three - Five Years - - PowerPoint PPT Presentation

Federal Pharmacy Senior Leaders Vision: Next Three - Five Years

CAPT Brian LaPlant, US Public Health Service CDR Paul Michaud, US Coast Guard CDR Ron Nosek, USN (Ret), Dept. of Veterans Affairs Col Dave Bobb, USAF (Ret), Defense Health Agency CAPT Brandon Hardin, US Navy Col Melissa Howard, US Air Force COL Kevin Roberts, US Army

The American Pharmacist Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. CAPT Brian LaPlant, USPHS; CDR Ron Nosek, USN (Ret) VA; CDR Paul Michaud, USCG; Col Dave Bobb, USAF (Ret) DHA; CAPT Brandon Hardin, USN; Col Melissa Howard, USAF; and COL Kevin Roberts, USA “declare no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.”

CPE Information and Disclosures

 Target Audience: Pharmacists and Pharmacy Technicians  ACPE#: 0202-0000-18-205-L04-P/T  Activity Type: Knowledge-based

CPE Information

Learning Objectives

• 1. State joint and service-specific key initiatives and their impact on

pharmacy operations and patient care services.

• 2. Discuss strategic goals and the impact their implementation will have
• n the delivery of care.
• 3. List examples of federal pharmacy programs that improve access and

quality of care to our military and veteran populations.

• 4. Discuss the DoD Military Medicine transition and organization changes

under the Defense Health Agency.

Self-Assessment Questions

 Rear Admiral Ty Bingham, new CPO for the USPHS lists which of the

the following priorities for USPHS Pharmacists?

A. National Opioid Crisis Response B. Team Medicine Approach C. Pharmacists in Direct Patient Care Roles D. Documenting Pharmacist Impact Across the Nation E. All of the above

Self-Assessment Questions

 Which of the following are Centralized Models of Pharmacy Care in

the VA?

A. Consolidated Mail Outpatient Pharmacy (CMOP) B. Virtual Pharmacy Services C. Anticoagulation Hubs D. All of the above

Self-Assessment Questions

 What Electronic Health Record system has the U.S. Coast Guard

chosen to implement?

A. EPIC B. MHS Genesis C. Allscripts D. GE Healthcare

Self-Assessment Question

 The Defense Health Agency will become responsible for healthcare

• perations at all MTF pharmacies through a phased in approach that

started on 1 October 2018.

• A. True
• B. False

Self-Assessment Questions

 TRUE/FALSE: The MHS Prescription Drug Monitoring Program will

provide visibility of state prescription data to MTF users, but will not provide MTF prescription data to states for civilian providers to view.

Self-Assessment Questions

 Which of the following is a measure of performance that supports the

DHA Clinical Pharmacy Service Line?

a.

Wait time

b.

National Contract Compliance

c.

RVU's/FTE

d.

B2G

d.

All the above

e.

None of the above

U.S. Public Health Service

We Achieve It Together

Brian N. LaPlant, PharmD, MS, MHA Captain, USPHS North Central Regional Chief Pharmacist Bureau of Prisons

United States Public Health Service

 Prevention through Active Community Engagement (PACE)

 USPHS initiative to align community outreach activities with the initiatives of the Office of the Assistant Secretary for

Health and the Office of the Surgeon General

 Builds relationships

 Commissioned Corps  City/State Health Institutions  Education Institutions  Federal Partners  Local Communities

 Achievements

 81 individuals trained as trainers for naloxone administration  117 individuals trained on how to administer naloxone  Health Prevention Outreach to 2,453 individuals  54 officers conducted 296 hours of community service

 Goal to more fully engage pharmacists in this effort

PHS Pharmacists by Agency

Total Pharmacists* 1319 IHS 567 NIH 14 FDA 424 HRS A 14 BOP 152 DOD TMA 8 DHS 48 S AMHS A 5 CMS 46 AHRQ 1 CDC 24 ACF 1 OS 15

*As of 9/ 4/ 18

United States Public Health Service

 Office of the Surgeon General Priorities

 Opioids and Addiction  Tobacco  Health and the economy  Health and National Security  Emerging Public Health Threats  Oral Health  Community Health and Economic Prosperity

Better health through better partnerships.

• VADM Jerome Adams, Surgeon General

United States Public Health Service



Pharmacy Chief Professional Officer

 RADM Ty Bingham

 National Opioid Crisis Response  Team Medicine Approach  Pharmacists in Direct Patient Care Roles



Clinical Outcomes  Documenting Pharmacist Impact Across the Nation



Pharmacy Professional Advisory Committee

 26 Voting members, plus chair and chair elect  5 Subcommittees  Additional Workgroups

 Pharmacist Opioid Overdose Response Training Initiative (POORT)  Tobacco Cessation  ADAPT  Provider Status  VA-PHS BPS Prep Study Group

Pharmacy Opioid Overdose Response Training (POORT)

 Goals

 Train pharmacists to respond to opioid overdoses by connecting to community training programs  Connect with local communities and increase engagement

 Survey completed August 2018

 726 Pharmacy Officers completed  370 had received opioid training  61 identified as instructor for opioid overdose response training  137 officers carry naloxone

Image from: http:/ / www.wvxu.org/ post/ us-surgeon-general-brings- naloxone-message-northern-kentucky

Naloxone Initiatives/Partnerships

 USPHS Commissioned Officers  Alaska State Troopers  Alaska Health and Social Services

United States Public Health Service

 Food and Drug Administration

 Generic epinephrine 0.3 mg and 0.15 mg injector approval  Approval of atropine injection, 2mg/0.7ml, single dose autoinjector  Opioid Epidemic Response

 POORT activities  Advancing the development of improved medication-assisted treatments of opioid use disorder  Final Approval of the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS)  Inter-agency collaborations

 Treatment guidelines  Task forces

United States Public Health Service

 National Clinical Pharmacy Specialist

 297 Active Certifications  216 Pharmacists  4 Agencies

 BOP  IHS  USCG  ICE

 29 Pharmacists certified under the revised,

comprehensive criteria

United States Public Health Service

 NCPS Outcomes

 Data standardization for each disease state  Anticoagulation

Year # of Facilities Total Visits Total Patients Total Providers Average TTR by clinic Avg TTR by Patient FY 2014 2 914 54 5 58.7% 58.79% FY 2015 38 27709 2245 225 65.01% 63.52% FY 2016 37 27548 2039 211 66.72% 67.68% FY 2017 63 40707 3156 365 68.07% 67.22% Grand Total 140 96878 7494 809 66.75% 66.18%

United States Public Health Service

 NCPS Outcomes (continued)

 Diabetes  HIV

Year # of Facilities Total Patients Total Visits Average baseline A1c Average of A1c change FY 2015 7 787 5093 9.9

• 1.6

FY 2016 11 840 7008 10.2

• 1.8

FY 2017 19 2458 9510 10.1

• 1.8

Grand Total 37 4085 21611 10.1

• 1.7

Year # of Facilities Total Visits Total Patients Average of Base VL <50 (% pts) Average of end VL <50 (% pts) Absolute improvement in %

• f patients

FY 2017 5 1005 171 46.9% 82.86% 35.95%

United States Public Health Service

 NCPS Outcomes (continued)

 HTN (FY 2013 to FY 2017)  Tobacco Cessation (FY 2008 to FY 2017)

Year # of Facilities Total Visits Total Patients Avg baseline systolic Avg baseline diastolic Change in systolic Change in diastolic Grand total 24 11289 3213 144 84

• 11.46
• 6.57

Year # of Facilities Total Visits Total Patients 6 month quit rate (avg by clinic) Grand total 44 17476 6391 25.61%

Bureau of Prisons

 Awarded 2018 Category III APhA Foundation Pinnacle Award  Collaborative Practice Agreements

 274 CPAs, 103 Pharmacists

 Certifications

 38 Pharmacists with BPS Certifications  32 Pharmacists with NCPS Certifications

 Clinical Outcomes

 Diabetes

 2.1% decrease in HbA1c

 HIV

 92% undetectable viral load

 Hepatitis C

 87% SVR

Key Points

 Pharmacists are an integral part of the response to the opioid crisis  It is important for pharmacists to continue to transition into direct patient care roles

 “If you dislike change, you’re going to dislike irrelevance even more”

– General (Ret.) Eric Shinseki

 Clinical outcomes should be objective, standardized, and communicated

 Documenting pharmacist impact across the nation

Federal Pharmacy Leaders Vision: Next Three to Five Years

CDR Ronald A. Nosek, Jr., US Navy (Ret) RPh, MS, FAPhA, FASHP Department of Veterans Affairs

Overview and Key Initiatives

 VHA and PBM Overview  Top Priorities Next 3-5 years EHR Modernization Community Care for Veterans Centralized Models of Pharmacy Care Suicide Prevention

 VHA is the largest integrated health system in the United States.  172 VA Medical Centers  1,062 Outpatient Points of Care  >9 million enrolled Veterans  Pharmacy Services  Approximately 8,300 Pharmacists; 600 Residents/Fellows; 4,400 Technicians  260 outpatient pharmacies; 7 mail order pharmacies  151.5 million Rx’s annually (>80% filled by mail)  Drug Cost: $4.8 billion (FY2017)

Veterans Health Administration

VA Electronic Health Record Modernization

VA Electronic Health Record Modernization

VA Electronic Health Record Modernization

 Started with Veterans CHOICE Program in 2015  VA MISSION Act of 2018 (signed in June)  Ensure easy and reliable access to care when they need it.  Provide exceptional care to Veterans anytime, anywhere.  Serve as a trusted, caring partner, helping Veterans and their families be healthy and well  In place by October 2019  Provides $5.2 billion for continuation of existing community care programs  Consolidating various community care programs into ONE program that is easy to

understand, simple to administer and meets the need of Veterans and their families.

Community Care for Veterans

 Retail Pharmacy Network for Urgent/Emergent Prescriptions

 Four regional contracts  Contractor to establish a retail pharmacy network to fill urgent/emergent prescriptions received from CCN

providers and VA providers for prescription fulfillment.

 An urgent/emergent prescription is available for a maximum 14 day supply of medication without refills.  CCN Providers must use VA’s Urgent/Emergent Formulary  Routine/maintenance prescriptions to be forwarded to VA pharmacy  VA will transmit a list of all VA providers who are eligible to prescribe prescriptions  CCN pharmacist to dispense prescriptions in accordance with VA Pharmacy program’s mandatory generic

substitution policy

Community Care for Veterans

 Consolidated Mail Outpatient Pharmacy (CMOP)  Virtual Pharmacy Services  Anticoagulation Hubs

Centralized Models of Pharmacy Care

VA CMOP Rated Among the Best:

2010 (highest score) 2011 (highest score) 2012 (highest score) 2013 (highest score) 2014 (highest score) 2015 (highest score) 2016 Among the Best 2017 (highest score) 2018 (highest score)

Consolidated Mail Outpatient Pharmacy (CMOP)

 VA Policy requires prescriptions marked for mail delivery be processed within two working days of receipt  Many VAMC’s have difficulty meeting that requirement. Have significant backlog of “pending file”

prescriptions

 Delay in prescription fulfillment  Possible disruption in drug therapy  Patient dissatisfaction with pharmacy service  Increase in calls to pharmacy  Resources diverted away from patient care  Potential increase in medication errors  Significant use of overtime, compensatory time, contracts to meet workload

Virtual Pharmacy Services

Virtual Pharmacy Services

 Began as a pilot in 2011  Staffed by PBM Pharmacists located

in Dublin GA and Cheyenne WY.

 MOU between PBM and VAMC  Fee per Rx to cover operational

costs

 Prescriptions that are “straight

forward”

 23 current VAMC’s  3.6 million Rx’s in FY 2018  High levels of satisfaction reported  < 2 day Rx turnaround time  Greatly reduced or eliminated CT/OT

 Anticoagulation survey identified a lack of standardization of anticoagulation practices nationally  2-year pilot will be deployed initially in VISNs 10, 12, 15 and 23, supported by resources provided by the

Clinical Pharmacy Practice Office (CPPO) of Pharmacy Benefits Management (PBM) Services in VA Central Office (VACO).

 Marion, IL – VISN 15; scheduled to go live 9/2018  Iron Mountain, MI – VISN 12; scheduled to go live 9/2018  Minneapolis, MN – VISN 23; tentative start date 11/2018  Detroit, MI – VISN 10; tentative start date TBD

 Uses a hub and spoke model of care to build a regional solution that provides virtual anti-coagulation

services

Anticoagulation Hubs

Goals



Improve access, operational efficiency, clinical outcomes and lower overall costs while freeing up PCP, Specialist, Nursing and CPS time to take on additional roles



Use best practices from across country to create standardized procedures, protocols, templates etc.



Design new dashboards to assist with care



Roll out nationally via additional hubs Centralized Anticoagulation Service Hub (CASH)



Oversight by Clinical Pharmacy Practice Office



VISN Office Pharmacist Program Manager



Consolidated Work Unit

 5 Clinical Pharmacy Specialists (GS-13)  3 Pharmacy Technicians (GS-7)

Anticoagulation Hubs



VA/DoD Formulary: Focus on medications to treat psychiatric conditions, sleep disorders and pain management to ensure continuity of care of transitioning Veterans



Medication Take Back Programs

 Onsite receptacles (164) at 112 different VA facilities  Mail back envelopes available at all VA Medical Facilities for distribution to Veterans  As of June 30, 2018 collected 86.6 tons of product for disposal



Academic Detailing

 Opioid Use Disorder  Opioid Education and Naloxone Distribution (OEND)  Over 200,000 naloxone kits dispensed since Oct 2015

Pharmacy’s Role in Veteran Suicide Prevention

Pharmacy’s Role in Veteran Suicide Prevention

U.S. Coast Guard Pharmacy Program Updates

CDR Paul T. Michaud U.S. Coast Guard / U.S. Public Health Service

Learning Objectives

• 1. Challenges and Opportunities – Electronic Health Record
• 2. Pharmacy’s role in disaster management and emergency response
• 3. Strengthening Federal Partnerships
• 4. Make a Difference

Challenges and Opportunities

 Improved access to healthcare to ensure operationally ready members  Acquisition and implementation of an electronic health record  U.S. Public Health Service officer recruitment and retention

USCG Pharmacy Hurricane Response in 2018

 [INSERT KEY POINTS OF PRESENTATION AS REVIEW FOR AUDIENCE]

Strengthening Federal Partnerships

 U.S. Public Health Service  VA  International Pharmacy Community  DoD / DHA / DLA  DHS  OHA  Professional Organizations  Industry  Academic

U.S. Coast Guard Pharmacist Duties

Make a Difference

 Leave your legacy  You can’t steer a parked car  T.E.A.M.

Defense Health Agency Pharmacy Operations: Building the New…

Col David W. Bobb, USAF (Ret) RPh, JD Chief, Pharmacy Operations Division Defense Health Agency

I received this in an e-mail…

• From Star Wars…

“We are the Borg. Lower you shields and surrender your ships. We will add your biological and technical distinctiveness to our own. Your culture will adapt to service us. Resistance is futile…”

• A DoD Pharmacist version…

“We are the DHA. Lower you shields and surrender your MTFs. We will add your historical and military distinctiveness to our own. Your culture will adapt to service us. Resistance is futile…”

The Who, What, Why, etc.

• The ultimate goal of this transition for the Department of Defense is a more

integrated, efficient, and effective system of readiness AND health that best supports the lethality of the force.

• The number one priority of the Military Health System is readiness to support

the warfighting mission of the Department of Defense.

• The mission of Pharmacy Operations remains to support the warfighter, and

care for our warfighter families, retirees, and beneficiaries by innovatively managing and standardizing the DoD pharmacy benefit in a fiscally responsible manner to optimize readiness, improve health, and lower costs through better care.

Phased Approach to Transition, but…

• DHA developed a Phased approach to transition all MTFs that

consisted of 4 phases:

• Phase I (FY 19) – NCR, JAX+, WAMC+, Keesler, Charleston, SJ, Pope
• Phase II (FY 20) – Transition remainder of MTFs in the Eastern U.S.
• Phase III (FY 21) – Transition all MTFS in the Western U.S. plus Alaska
• Phase IV (FY 22) - Transition all MTFs outside of U.S.
• However, Pharmacy was one of three functional communities chosen

for accelerated transition. This means that the DHA became responsible for all MTF pharmacy healthcare operations on 1 October 2018.

What This Means

• DHA is responsible for healthcare operations at MTF pharmacies
• Services remain responsible for readiness
• We have the opportunity to leverage both the direct care and

purchased care aspects of the pharmacy benefit to optimize pharmacy services for our beneficiaries

• Standardize, consolidate, and centralize policies, procedures, and

processes across the pharmacy enterprise

• Across the enterprise, we can implement the best programs and

processes that each Service is currently doing

What Stays the Same at the MTF

• Deployments and readiness operations
• Providing pharmacy services and taking care of patients
• Support to installation operations
• Executing the MTF budget
• DHA’s centralization & support for information technology (already provided)
• Personnel performance evaluations
• Administrative functions (ex., fitness, leave, duty status, pay inquiries, etc.)
• Recruiting, organizing, training and equipping medical personnel
• UCMJ/discipline of uniformed personnel
• Assuring health, safety, morale and welfare of personnel
• Supporting families

What Changes at the MTF

• DHA will issue standardized policy, procedures and processes
• All Service policies remain in place until a DHA policy is issued
• DHA will approve and monitor MTF performance plans (QPP)
• DHA will fund MTFs, but execution of the budget remains local
• DHA will direct military medical construction
• Additional reliance on a market structure

Pharmacy Benefit/POD Changes

• Introduction of a “Tier 4” formulary exclusionary status for

medications

• More robust formulary management (inpatient, medical benefit)
• Increased emphasis on clinical pharmacy services
• Implementation of a DoD Prescription Drug Monitoring Program
• Centralization and standardization of pharmacy automation

equipment

• POD organizational structure
• Pharmacy Working Group (PWG) remains in place as the “work

engine” of the decision-making process

DHA Healthcare Operations

eMSMs, Large MTF Markets, Small MTFs (6) Pharmacist Market Leaders (O-6)

Pharmacy Information Operations Formulary Management Purchased Care MTF Administration

MTFs

Strategy Management Pharmacy Consultants (Readiness)

Market Level

(notional)

HQ Level

PWG

MTF Level

TRICARE HEALTH PLAN (J-10)

S ervice S Gs

Pharmacy Division Chief & Deputy

POD Organization Structure

Think About It…

The secret of Change is to focus all of your energy not on fighting for the old, but on building the New.

• Socrates

It is not the strongest of the species that survives, nor the most intelligent that survives. It is the one that is the most adaptable to change.

• Charles Darwin

Key Point

 The DHA transition allows us to leverage the best of both direct care

and purchased care pharmacy services to optimize the benefit for all beneficiaries.

Federal Pharmacy Senior Leaders Vision: Next 3-5 Years

CAPT Brandon Hardin United States Navy

MHS Prescription Data Monitoring Program (PDMP)

1

PDMP Background

2

DoD Current State

3

MHS PDMP Solution

4

Policy Development

PDMP Background

President’s Commission Report Nov 2017 NDAA 2019 | Section 715 – Sharing of Information with State PDMPs Prescription drug abuse is a national epidemic Operational PDMPs: 49 states, DC, Guam, Puerto Rico

DoD’s Current State

Sharing Blind Spots

• Tricare Retail and Mail Orders fills

– with state PDMPs

• All Tricare Retail, Mail Order, and

MTF fills – with MTFs

• Civilian Providers – MTF fills
• MTF Providers – cash and OHI

fills

MHS PDMP – Solution

Express Scripts, Inc. National Association of Boards of Pharmacy (NABP)

 DoD becomes another “state”  CII-V MTF data will be posted daily  Begin use 1 January 2019  DoD users will register for access

Policy Development

Mandatory registration: 41 Mandatory query: 42 Mandatory training: 14

Key Points

 New MHS PDMP will eliminate the blind spots for civilian and MTF prescribers and

dispensers caring for Tricare patients

 PDMPs are proven to impact the prescription drug problem  Go Live expected by 1 January 2019

Answers To Self-Assessment Questions

 TRUE/FALSE: The MHS Prescription Drug Monitoring Program will provide visibility of state prescription

data to MTF users, but will not provide MTF prescription data to states for civilian providers to view.

 FALSE

Federal Pharmacy Senior Leaders Vision: Next Three - Five Years

Col Melissa Howard United States Air Force

DHA Technology Update

MHS GENESIS Rationalization and Standardization Pharmacy Inpatient Automation System (PIAS) Pharmacy Outpatient Workflow System (POWS) Additional Initiatives

MHS GENESIS

 Go Live: February 2017

 Fairchild AFB

Rationalization and Standardization

Workflows leveraging advancing technologies Rationalization = Standardization

Review everything currently in the field Rationalize the need and requirements Standardize to the best products

Pharmacy Inpatient Automation System

PIAS Pyxis ES Enterprise solution

Pharmacy Outpatient Workflow System (POWS)

What is workflow? Isn’t this the same as automation? Why workflow and not automation?

Additional Initiatives

PDS: Pharmacy Drug Standardization Windows 10 and Tech Refresh

Additional Initiatives

Regional Refill Centers

Key Points

 MHS GENESIS  Rationalization and Standardization  Pharmacy Inpatient Automation System (PIAS)  Pharmacy Outpatient Workflow System (POWS)  Additional Initiatives

DHA Clinical Pharmacy Service Line

Kevin W. Roberts, COL, MS Pharmacy Consultant to the USA Surgeon General Director, USA Pharmacy Service Line

Learning Objectives

 List current areas of focus for the DHA Clinical Pharmacy Service Line.  Define initial measures of performance for the DHA Clinical Pharmacy

Service Line.

 Discuss milestones associated with development and implementation

• f the DHA Clinical Pharmacy Service Line.

OUTLINE

 BACKGROUND  CPSL AREAS OF INTEREST  CPSL FOCUS  MILESTONES  MEASURES OF PERFORMANCE/EFFECT  DHA CPSL WORK GROUP  CLOSING REMARKS

BACKGROUND--MHS Operating Model Purpose Statement

To enable front line clinicians t o drive Ent erprise-wide performance improvement s in readiness and healt h; empower Ent erprise-level Clinical Communit ies t o creat e condit ions for high reliabilit y at t he point of care (processes, st andards, met rics); and hold ourselves account able t o MHS st andards and clinical out comes.

BACKGROUND

BACKGROUND

• The Clinical Pharmacy Service Line (CPSL) is one of three lines of effort utilized by the

DHA Pharmacy Operations Division to improve provision of healthcare within the MHS.

• Purpose: The Clinical Pharmacy Service Line will enhance readiness, improve health, and

lower costs of care through optimized provision of pharmaceutical care.

• Established multi-service workgroup in May 2018
• Goals
• Standardize manning, processes and accounting of clinical pharmacy services.
• Collaborative development with best practices (to include Services, VA and Public Health)
• Guide/develop DHA foundational publications

CPSL Areas of Interest

• Coding
• Reporting
• Staffing
• Civilian PD’s
• Credentialing and Privileging
• Metrics (performance/effectiveness)
• Training and Competency Assessment
• Ready Medical Force/Medically Ready Force
• Analytics Team

CPSL FOCUS

• Coding: Identified significant variance among services
• Engaged DHA coding work group
• Ultimate goal: DHA instruction manual
• Resources
• Personnel
• Clinical Pharmacists (1:6,500 Prime Enrollees)
• Clinical Technicians
• Interventional Software
• Position Standardization
• Various position descriptions being consolidated
• Position/Pay parity

CPSL FOCUS

• Measures of Performance
• RVU’s/FTE
• % patient care time/RVU
• Measures of Effect
• Disease specific
• Quality
• Readiness
• Polypharmacy
• Potentially deployment limiting medication

CPSL FY19 MILESTONES

• Provide resource requirements to Director, DHA POD by 1 October 2018.
• Establish a Service Member readiness metric by 1 October 2018 (Army Lead)
• Establish DHA CPSL PI by 31 March 2019 (Air Force Lead)
• Submit standard PD’s by 31 March 2019 (Navy Lead)
• Establish standard credentialing/privileging process by 31 March 2019

DHA’s CPSL Work Group

COL Kevin Roberts, (co-chair/consultant champion), USA

Col Melissa Howard (co-chair/consultant champion), USAF

• Dr. David Meade (co-chair), DHA

COL Jeff Neigh, USA

• Dr. Jennifer Evans, DAC, USA

LtCol Heather Fenzl, USAF LtCol Julie Meek, USAF Maj Sokunthea Peou, USAF CDR Janel Rossetto, USN LCDR Reina Gomez, USN

• Dr. Alexandra Vance, DAC, USN

LTC(P) Mark Maneval, USA, DHA CDR Thien Nguyen, USPHS, DHA

• Dr. Ingrid Svihla, DAC, DHA

“ One Team – One Purpose, Conserving the Fighting S trength”

Answers to Self-Assessment Questions

 Rear Admiral Ty Bingham, new CPO for the USPHS lists which of the

the following priorities for USPHS Pharmacists?

A. National Opioid Crisis Response B. Team Medicine Approach C. Pharmacists in Direct Patient Care Roles D. Documenting Pharmacist Impact Across the Nation E. All of the above

Answers to Self-Assessment Questions

 Which of the following are Centralized Models of Pharmacy Care in

the VA?

A. Consolidated Mail Outpatient Pharmacy (CMOP) B. Virtual Pharmacy Services C. Anticoagulation Hubs D. All of the above

Answers To Self-Assessment Questions

 What Electronic Health Record system has the U.S. Coast Guard

chosen to implement?

A. EPIC B. MHS Genesis C. Allscripts D. GE Healthcare

Answers To Self-Assessment Question

• The Defense Health Agency will become responsible for healthcare
• perations at all MTF pharmacies through a phased in approach

that started on 1 October 2018.

• A. True
• B. False

Answers To Self-Assessment Questions

 TRUE/FALSE: The MHS Prescription Drug Monitoring Program will

provide visibility of state prescription data to MTF users, but will not provide MTF prescription data to states for civilian providers to view.

 FALSE

Answers to Self-Assessment Questions

 Which of the following is a measure of performance that supports the

DHA Clinical Pharmacy Service Line: a. Wait time b. National Contract Compliance c. RVU's/FTE d. B2G d. All the above e. None of the above

Federal Chiefs’ Panel Discussion

Your Questions and Comments are Encouraged and Welcomed

Closing Remarks / Contact

CAPT Brian LaPlant, US Public Health Service

Email: blaplant@bop.gov P: 417-836-1338

CDR Paul T. Michaud, US Coast Guard

Email: Paul.T.Michaud@uscg.mil P: 202-475-5171

CDR Ron Nosek , USN (Ret), Department of Veterans Affairs

Email: Ron.nosek@va.gov P: 814-215-4374

Closing Remarks / Contact

Col Dave Bobb, USAF (Ret), Defense Health Agency

Email: David.w.bobb.civ@mail.mil P: 703-681-2890

CAPT Brandon Hardin, US Navy

Email: Brandon.w.hardin.mil@mail.mil P: 703-681-9119

Col Melissa Howard, US Air Force

Email: Melissa.r.howard.mil@mail.mil P: 703-681-7880

COL Kevin Roberts, U.S. Army

Email: kevin.w.roberts18.mil@mail.mil P: 703-681-5959